BP term

GO:0030155

regulation of cell adhesion

5

2.93E−08

1.29E−07

CC term

GO:0005604

basement membrane

11

2.98E−23

3.87E−22

CC term

GO:0098637

protein complex involved in cell-matrix adhesion

5

5.58E−12

3.62E−11

CC term

GO:0005576

extracellular region

12

1.43E−11

6.21E−11

CC term

GO:0043256

laminin complex

4

3.98E−09

1.29E−08

CC term

GO:0043083

synaptic cleft

4

1.10E−07

2.86E−07

CC term

GO:0043259

laminin-10 complex

3

7.80E−07

1.01E−06

CC term

GO:0005606

laminin-1 complex

3

7.80E−07

1.01E−06

CC term

GO:0005608

laminin-3 complex

3

7.80E−07

1.01E−06

CC term

GO:0005610

laminin-5 complex

3

7.80E−07

1.01E−06

CC term

GO:0043260

laminin-11 complex

3

7.80E−07

1.01E−06

MF term

GO:0005201

extracellular matrix structural constituent

11

3.43E−21

3.43E−20

MF term

GO:0005198

structural molecule activity

6

3.99E−08

1.99E−07

MF term

GO:0005102

receptor binding

5

5.67E−05

1.89E−04

MF term

GO:0005178

integrin binding

4

9.57E−05

2.39E−04

kegg

hsa04512

ECM-receptor interaction

12

1.20E−22

1.41E−21

kegg

hsa05222

Small cell lung cancer

12

2.01E−22

1.41E−21

kegg

hsa05146

Amoebiasis

12

6.67E−22

3.11E−21

kegg

hsa05145

Toxoplasmosis

12

1.96E−21

6.87E−21

kegg

hsa04510

Focal adhesion

12

1.54E−18

4.30E−18

kegg

hsa05165

Human papillomavirus infection

12

4.14E−16

9.66E−16

kegg

hsa04151

PI3K-Akt signaling pathway

12

8.77E−16

1.75E−15

kegg

hsa05200

Pathways in cancer

12

7.99E−14

1.40E−13

kegg

hsa05416

Viral myocarditis

2

0.07798259

0.12130626

kegg

hsa05412

Arrhythmogenic right ventricular cardiomyopathy

2

0.09904928

0.13866899